FDA warned NV Nutrition that its inhalable vaporizer and diffuser products are drugs sold without FDA approval and promoted with disease claims.
What happened
In October 2021, FDA reviewed NV Nutrition's websites, social media pages, and product packaging and found claims that the vaporizer and diffuser products treat or manage conditions such as insomnia, anxiety, hangovers, and immune problems. FDA said the products are intended for inhalation, not ingestion, so they do not meet the dietary supplement definition, and no approved drug applications are in effect.
What FDA found
The products are new drugs because they are not generally recognized as safe and effective for their claimed uses and no approved applications are in effect.
FD&C Act sections 201(p), 505(a), and 301(d), 21 U.S.C. 321(p), 355(a), and 331(d)Website, social media, and packaging claims show the products are intended to cure, mitigate, treat, or prevent disease or affect body structure or function, making them drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products carry Supplement Facts panels but are intended for inhalation, not ingestion, so they are not dietary supplements.
FD&C Act section 201(ff)(2)(A)(i), 21 U.S.C. 321(ff)(2)(A)(i)The products are introduced or delivered for introduction into interstate commerce without an approved new drug application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA tells the company to notify it in writing within 15 working days of receipt of the letter with the specific steps taken to address the violations, an explanation of each step, and related documentation. If the company believes it is not violating the law, it must include its reasoning and supporting information; if it cannot complete the work in time, it must state why and when it will.
Who should pay attention
- companies selling inhalable supplements or vaporizer/diffuser products
- e-commerce brands that make disease or structure/function claims
- contract manufacturers and packagers of inhalable wellness products
This is a summary. Read the original letter on fda.gov.